Skip to content
Austin Top 50
Author:
Harbour Biomed
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
June 10, 2026
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
June 9, 2026
←
Previous Page
1
2
3